Long-term follow-up of a phase III Study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors : The Indiana University experience

Long-term follow-up of a phase III Study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors : The Indiana University experience

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical oncology 1998-02, Vol.16 (2), p.702-706
Hauptverfasser: SAXMAN, S. B, FINCH, D, GONIN, R, EINHORN, L. H
Format: Artikel
Sprache:eng
Schlagworte:
Biological and medical sciences
Gynecology. Andrology. Obstetrics
Male genital diseases
Medical sciences
Tumors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 706
container_issue 2
container_start_page 702
container_title Journal of clinical oncology
container_volume 16
creator SAXMAN, S. B
FINCH, D
GONIN, R
EINHORN, L. H
description
doi_str_mv 10.1200/JCO.1998.16.2.702
format Article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_2152508</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2152508</sourcerecordid><originalsourceid>FETCH-LOGICAL-p182t-eb36af2d259fca7257daf18d9cfa2290b75e7b632cece6498c50c3f03e5daf053</originalsourceid><addsrcrecordid>eNotkM9qGzEQh0VpoW7SB-htDj1GW_2JrN3eimkTB0MOTaC3IGtHtoosCWk3zT5ZX68yDQwMzO9jPmYI-cRZxwVjX-429x0fhr7j6050mok3ZMWV0FRrpd6SFdNSUN7LX-_Jh1p_M8ave6lW5O8uxQOdsJzApRDSHzpnSA4M5KOpCNvtFn5O87ich9OxIMIzljrXhs8F7GID1nO2D5hOi_XxCnBKOVU_4hWYOIL1NQcz-QitnHlOxTSY5pIOsWEVDs1OLYYA03xKpcJXeDg2dRy9iQYeoz8r_bQAvmQsHqPFS_LOmVDx42u_II8_vj9sbunu_ma7-bajmfdioriXa-PEKNTgrNFC6dE43o-DdUaIge21Qr1fS2HR4vp66K1iVjomUTWQKXlBPv_fm021JrhiYrvnKRd_MmV5Eu3HivXyHxxtePk</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Long-term follow-up of a phase III Study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors : The Indiana University experience</title><source>American Society of Clinical Oncology Journals</source><source>Journals@Ovid Complete</source><creator>SAXMAN, S. B ; FINCH, D ; GONIN, R ; EINHORN, L. H</creator><creatorcontrib>SAXMAN, S. B ; FINCH, D ; GONIN, R ; EINHORN, L. H</creatorcontrib><identifier>ISSN: 0732-183X</identifier><identifier>EISSN: 1527-7755</identifier><identifier>DOI: 10.1200/JCO.1998.16.2.702</identifier><language>eng</language><publisher>Baltimore, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Biological and medical sciences ; Gynecology. Andrology. Obstetrics ; Male genital diseases ; Medical sciences ; Tumors</subject><ispartof>Journal of clinical oncology, 1998-02, Vol.16 (2), p.702-706</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2152508$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>SAXMAN, S. B</creatorcontrib><creatorcontrib>FINCH, D</creatorcontrib><creatorcontrib>GONIN, R</creatorcontrib><creatorcontrib>EINHORN, L. H</creatorcontrib><title>Long-term follow-up of a phase III Study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors : The Indiana University experience</title><title>Journal of clinical oncology</title><subject>Biological and medical sciences</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Male genital diseases</subject><subject>Medical sciences</subject><subject>Tumors</subject><issn>0732-183X</issn><issn>1527-7755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNotkM9qGzEQh0VpoW7SB-htDj1GW_2JrN3eimkTB0MOTaC3IGtHtoosCWk3zT5ZX68yDQwMzO9jPmYI-cRZxwVjX-429x0fhr7j6050mok3ZMWV0FRrpd6SFdNSUN7LX-_Jh1p_M8ave6lW5O8uxQOdsJzApRDSHzpnSA4M5KOpCNvtFn5O87ich9OxIMIzljrXhs8F7GID1nO2D5hOi_XxCnBKOVU_4hWYOIL1NQcz-QitnHlOxTSY5pIOsWEVDs1OLYYA03xKpcJXeDg2dRy9iQYeoz8r_bQAvmQsHqPFS_LOmVDx42u_II8_vj9sbunu_ma7-bajmfdioriXa-PEKNTgrNFC6dE43o-DdUaIge21Qr1fS2HR4vp66K1iVjomUTWQKXlBPv_fm021JrhiYrvnKRd_MmV5Eu3HivXyHxxtePk</recordid><startdate>19980201</startdate><enddate>19980201</enddate><creator>SAXMAN, S. B</creator><creator>FINCH, D</creator><creator>GONIN, R</creator><creator>EINHORN, L. H</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope></search><sort><creationdate>19980201</creationdate><title>Long-term follow-up of a phase III Study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors : The Indiana University experience</title><author>SAXMAN, S. B ; FINCH, D ; GONIN, R ; EINHORN, L. H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p182t-eb36af2d259fca7257daf18d9cfa2290b75e7b632cece6498c50c3f03e5daf053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Biological and medical sciences</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Male genital diseases</topic><topic>Medical sciences</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SAXMAN, S. B</creatorcontrib><creatorcontrib>FINCH, D</creatorcontrib><creatorcontrib>GONIN, R</creatorcontrib><creatorcontrib>EINHORN, L. H</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SAXMAN, S. B</au><au>FINCH, D</au><au>GONIN, R</au><au>EINHORN, L. H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term follow-up of a phase III Study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors : The Indiana University experience</atitle><jtitle>Journal of clinical oncology</jtitle><date>1998-02-01</date><risdate>1998</risdate><volume>16</volume><issue>2</issue><spage>702</spage><epage>706</epage><pages>702-706</pages><issn>0732-183X</issn><eissn>1527-7755</eissn><cop>Baltimore, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><doi>10.1200/JCO.1998.16.2.702</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0732-183X
ispartof Journal of clinical oncology, 1998-02, Vol.16 (2), p.702-706
issn 0732-183X
1527-7755
language eng
recordid cdi_pascalfrancis_primary_2152508
source American Society of Clinical Oncology Journals; Journals@Ovid Complete
subjects Biological and medical sciences
Gynecology. Andrology. Obstetrics
Male genital diseases
Medical sciences
Tumors
title Long-term follow-up of a phase III Study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors : The Indiana University experience
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T01%3A41%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20follow-up%20of%20a%20phase%20III%20Study%20of%20three%20versus%20four%20cycles%20of%20bleomycin,%20etoposide,%20and%20cisplatin%20in%20favorable-prognosis%20germ-cell%20tumors%20:%20The%20Indiana%20University%20experience&rft.jtitle=Journal%20of%20clinical%20oncology&rft.au=SAXMAN,%20S.%20B&rft.date=1998-02-01&rft.volume=16&rft.issue=2&rft.spage=702&rft.epage=706&rft.pages=702-706&rft.issn=0732-183X&rft.eissn=1527-7755&rft_id=info:doi/10.1200/JCO.1998.16.2.702&rft_dat=%3Cpascalfrancis%3E2152508%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true